|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/00 | (2006.01) | ||
| C07K 16/46 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3135691 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16192250.5 |
| Date of filing the European patent application | 2009-12-02 | |
| (97) | Date of publication of the European application | 2017-03-01 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-15 |
| (46) | Date of publication of the claims translation | 2018-11-12 |
| (30) | Number | Date | Country code |
| PCT/IB2008/0556 | 2008-12-02 | WO | |
| 184502 P | 2009-06-05 | US |
| (72) |
GOETSCH, Liliane, FR
WURCH, Thierry, FR
BES, Cédric, ES
|
| (73) |
PIERRE FABRE MEDICAMENT,
45 place Abel Gance, 92100 Boulogne-Billancourt,
FR
|
| (74) |
Aurelija ŠIDLAUSKIENĖ,
Dr. V. Šidlauskas ir partneriai, UAB, K. Būgos g. 29, LT-44326 Kaunas,
LT
|
| (54) | Anti-cMet antikūnai |
| ANTI-CMET ANTIBODY |
| Payment date | Validity (years) | Amount | |
| 2024-11-28 | 16 | 347.00 EUR |
| 2025-12-02 |